Highest Sampling Of Ayurvedic Medicine In Kerala, Hence Maximum Samples Failed

THIRUVANANTHAPURAM : Kerala has reported the most number of ayurvedic products that are ‘not of standard quality’ (NSQ) in the country. As many as 113 ayurvedic drugs sold in the state were found to be of poor quality. Kerala was followed by Maharashtra with 21 products, said Union Minister for Ayush, Sarbananda Sonowal in reply to a question raised by MP Ramya Haridas in the Lok Sabha on December 16.

He also listed the action taken by drug controllers of different states in a period from 2019 to 2022. Under the Drugs and Cosmetics Act, 1940, Assam’s drug controller found 52 non-compliant samples between 2020 and 2021. It should be noted that 10 states, including Uttar Pradesh, Punjab and Madhya Pradesh, and three Union territories did not report a single case in any category.

Health experts said the list is not comprehensive, but they pointed out that Kerala does have a lot of poor quality drugs and that the drug controller is more active as well.

“The state drug controller is doing a great job by testing ayurvedic drugs to find out those which are not up to standard. It’s a step in the right direction. I hope the state licensing authority will initiate stringent action against those who are violating the drug laws,” said Dr Babu K V, a health activist from Kannur. The controller has actively followed up on drug companies violating regulations, he added.

Dr Raju Thomas, the previous president of the Ayurveda Medical Association of India, said most of the poor quality drugs come from outside the state. “We have a very good regulatory system. But it is a daunting task to check all the drugs that reach the market. There should be an independent regulator with enough manpower for Ayush to make the system more effective,” he added. Drugs controller P M Jayan did not respond to TNIE’s calls seeking a comment.

  • Related Posts

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states